Effects of Dry Needling on Stiffness in Latent Trigger Points a Randomized Controlled Trial
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Trigger Point Pain, Myofascial
- Sponsor
- University of Castilla-La Mancha
- Enrollment
- 50
- Locations
- 1
- Primary Endpoint
- Change in Maximal Radial Displacement (Dm)
- Status
- Completed
- Last Updated
- 5 years ago
Overview
Brief Summary
The purpose of this study is to determine whether application of Dry Needling (DN) is effective for improved Muscle Mechanical Properties and Muscle Contractility in Latent Trigger Points point (LTrP) of upper trapezius. Randomized controlled trial, in parallel with cross-control design. Two groups with LTrP in upper trapezius, and will be randomly selected to DN group or Sham-Dn group.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Age between 18 and 30 years
- •The presence of LTrP in the middle third of the upper trapezius muscle on the dominant side
- •Being able to provide written informed consent
- •Being able to follow instructions and realize clinical tests
Exclusion Criteria
- •Any pharmacological therapeutic
- •Any medical treatment or physical therapies at cervical region during the 6-month before this study - Any diagnosed health problem
- •Any history of head and upper extremity surgery or trauma
- •Any red flags to DN, (ie: metabolic diseases, pregnancy, kinesiophobia, Infection, cancer)
- •Absence of recurrent history of neck pain
- •No neck pain symptomatology the previous 6 months
- •Cervical disk herniation
Outcomes
Primary Outcomes
Change in Maximal Radial Displacement (Dm)
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
This outcome measure is obtained by a device named Tensiomiography. The variable Dm is given by the radial displacement of the muscular belly in a transverse plane, expressed in millimeters (mm) and depends on muscle tone or stiffness. A low Dm is related to a high muscle tone or an excess of stiffness, while a high Dm value indicates a lack of muscle tone or stiffness defect.
Change in Stiffness
Time Frame: Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment
This outcome measure is obtained by a device named MyotonPro. Stiffness reflects the resistance of the muscle to the force deforming the muscle.
Secondary Outcomes
- Change in Oscillation Frequency(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Mechanical Stress Relaxation Time [ms](Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Decrement (elasticity)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Sustain time (Ts)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Relaxation time (Tr)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Pressure Pain Perception (PPP)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Ratio of deformation and Relaxation time, characterising Creep (Deborah number)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Contraction time (Tc)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)
- Change in Delay time (Td)(Baseline, at 30 minutes after treatment, at 24 hours after treatment, at 72 hours after treatment)